
Atcef-SB 1000mg/500mg Injection
Marketer
Atishya Biotech
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Atcef-SB 1000mg/500mg Injection
Cefoperazone/Sulbactam 1000mg/500mg injection is a dual-action antibiotic. It's used to combat diverse bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a qualified medical practitioner. Strictly adhere to the prescribed dosage schedule; completing the entire course is crucial, even with symptom improvement. Premature cessation may compromise treatment efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms promptly. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving is discouraged if drowsiness or dizziness occurs. Prioritize rest, nutrition, and hydration for optimal recovery. Monitoring through lab tests may be undertaken to assess treatment response.
Primary Ingredients of Atcef-SB 1000mg/500mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Atcef-SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Atcef-SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Atcef-SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Atcef-SB 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Atcef-SB 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Atcef-SB 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thereby potentiating Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Atcef-SB 1000mg/500mg Injection shows no adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
Cefazolin injection (1000mg/500mg) is typically regarded as safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Cefazolin injection (1000mg/500mg) necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Cefazolin injection (1000mg/500mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Atcef-SB 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable formulation of Atcef-SB (1000mg/500mg) requires careful administration in individuals with advanced hepatic impairment. Dosage modification may be necessary; physician consultation is advised. Altering the dose of Atcef-SB (1000mg/500mg) injection is not suggested for those experiencing mild or moderate liver dysfunction.
What if you forget to take Atcef-SB 1000mg/500mg Injection :
Should you forget a scheduled Atcef-SB 1000mg/500mg Injection, seek medical advice immediately.
Facts to Know About Atcef-SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
